Literature DB >> 15958085

Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases.

M H Biezeveld1, G van Mierlo, R Lutter, I M Kuipers, T Dekker, C E Hack, J W Newburger, T W Kuijpers.   

Abstract

Kawasaki disease (KD) is an acute febrile syndrome of childhood, characterized by vasculitis of the medium-sized arteries. White blood cell counts and the inflammatory parameter C-reactive protein (CRP) are known to be elevated in the acute phase of the disease. In this study we investigated the course of inflammatory cell type-specific parameters in KD over a longer period of time. Plasma levels of human neutrophil elastase (HNE), matrix metalloproteinases-2 and -9 (MMP2, MMP9), and neutrophil gelatinase-associated lipocalin (NGAL), macrophage neopterin and CRP were measured. Plasma samples were collected in the acute, subacute and early convalescent stage, and three months after the onset of disease. Median CRP and neopterin normalized within two weeks. In contrast, six weeks and three months after onset of disease, levels of HNE were still elevated, with median values of 163 ng/ml and 156 ng/ml, respectively (control children median < 50 ng/ml; for all time-points P < 0.0001). Values of NGAL correlated with the levels of HNE (r = 0.39, P = 0.013). These results demonstrate a longer state of neutrophil activation in KD than was previously assumed. The potential relationship between this prolonged neutrophil activation, coronary artery lesion formation and their persistence, as well as the risk of premature atherosclerosis warrants further evaluation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958085      PMCID: PMC1809423          DOI: 10.1111/j.1365-2249.2005.02829.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

Review 1.  Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  Pediatr Clin North Am       Date:  1999-04       Impact factor: 3.278

2.  Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset.

Authors:  M Fukunishi; M Kikkawa; K Hamana; T Onodera; K Matsuzaki; Y Matsumoto; J Hara
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

3.  Endothelial dysfunction late after Kawasaki disease.

Authors:  R Dhillon; P Clarkson; A E Donald; A J Powe; M Nash; V Novelli; M J Dillon; J E Deanfield
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

4.  The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease.

Authors:  S Takeshita; K Nakatani; H Kawase; S Seki; M Yamamoto; I Sekine; S Yoshioka
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

5.  Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury.

Authors:  G Ferry; M Lonchampt; L Pennel; G de Nanteuil; E Canet; G C Tucker
Journal:  FEBS Lett       Date:  1997-02-03       Impact factor: 4.124

6.  Elastase and granzymes during meningococcal disease in children: correlation to disease severity.

Authors:  Job B M van Woensel; Maarten H Biezeveld; C Erik Hack; Albert P Bos; Taco W Kuijpers
Journal:  Intensive Care Med       Date:  2005-07-12       Impact factor: 17.440

7.  Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment.

Authors:  B Schiller; G Elinder
Journal:  Acta Paediatr       Date:  1999-08       Impact factor: 2.299

8.  Complement activation in patients with sepsis is in part mediated by C-reactive protein.

Authors:  G J Wolbink; A W Bossink; A B Groeneveld; M C de Groot; L G Thijs; C E Hack
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

9.  Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease.

Authors:  M Zaitsu; Y Hamasaki; K Tashiro; M Matsuo; T Ichimaru; I Fujita; H Tasaki; S Miyazaki
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

Review 10.  Leucocyte activation markers in clinical practice.

Authors:  J A Viedma Contreras
Journal:  Clin Chem Lab Med       Date:  1999-06       Impact factor: 3.694

View more
  27 in total

1.  Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.

Authors:  Adnan N Kiani; Tianfu Wu; Hong Fang; Xin J Zhou; Chul W Ahn; Laurence S Magder; Chandra Mohan; Michelle Petri
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

2.  Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.

Authors:  K Ikeda; K Yamaguchi; T Tanaka; Y Mizuno; A Hijikata; O Ohara; H Takada; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2009-12-15       Impact factor: 4.330

3.  Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease.

Authors:  Mark M Mitsnefes; Thelma S Kathman; Jaya Mishra; Janis Kartal; Philip R Khoury; Thomas L Nickolas; Jonathan Barasch; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2006-10-27       Impact factor: 3.714

4.  Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.

Authors:  Marianna Fabi; Laura Andreozzi; Ilaria Frabboni; Ada Dormi; Elena Corinaldesi; Francesca Lami; Cristina Cicero; Bertrand Tchana; Rosa Francavilla; Monica Sprocati; Barbara Bigucci; Claudia Balsamo; Paola Sogno Valin; Giorgia Di Fazzio; Lorenzo Iughetti; Enrico Valletta; Federico Marchetti; Andrea Donti; Marcello Lanari
Journal:  Clin Rheumatol       Date:  2020-09-16       Impact factor: 2.980

5.  Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.

Authors:  Young Mi Hong; Hyun-Seung Jin; In Sook Park; Soo-Jong Hong
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

6.  Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis.

Authors:  Michiko Suzuki; Kristina M Wiers; Marisa S Klein-Gitelman; Kathleen A Haines; Judyann Olson; Karen B Onel; Kathleen O'Neil; Murray H Passo; Nora G Singer; Lori Tucker; Jun Ying; Prasad Devarajan; Hermine I Brunner
Journal:  Pediatr Nephrol       Date:  2008-01-17       Impact factor: 3.714

7.  Differential role of lipocalin 2 during immune complex-mediated acute and chronic inflammation in mice.

Authors:  Rangaiah Shashidharamurthy; Deepa Machiah; Jesse D Aitken; Kalyani Putty; Gayathri Srinivasan; Benoit Chassaing; Charles A Parkos; Periasamy Selvaraj; Matam Vijay-Kumar
Journal:  Arthritis Rheum       Date:  2013-04

8.  Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response.

Authors:  Sadeep Shrestha; Howard Wiener; Aditi Shendre; Richard A Kaslow; Jianming Wu; Aaron Olson; Neil E Bowles; Hitendra Patel; Jeffrey C Edberg; Michael A Portman
Journal:  Circ Cardiovasc Genet       Date:  2012-05-07

9.  Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy.

Authors:  L Landrø; J K Damås; T H Flo; L Heggelund; T Ueland; G E Tjønnfjord; T Espevik; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

10.  Lipocalin-2-induced proliferative endoplasmic reticulum stress participates in Kawasaki disease-related pulmonary arterial abnormalities.

Authors:  Zhaoling Shi; Yue Yin; Chen Li; Hui Ding; Nan Mu; Yishi Wang; Shanshan Jin; Heng Ma; Manling Liu; Jie Zhou
Journal:  Sci China Life Sci       Date:  2020-09-09       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.